Dibutyl squarate
| Names | |
|---|---|
| IUPAC name
3,4-Dibutoxy-3-cyclobutene-1,2-dione
| |
| Other names
Squaric acid dibutyl ester; SADBE
| |
| Identifiers | |
3D model (JSmol)
|
|
| 1968189 | |
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
| ECHA InfoCard | 100.157.137 |
| EC Number |
|
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C12H18O4 | |
| Molar mass | 226.272 g·mol−1 |
| Hazards | |
| GHS labelling: | |
| Warning | |
| H315, H317, H319, H335 | |
| P261, P264, P264+P265, P271, P272, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P313, P337+P317, P362+P364, P403+P233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
| |
Dibutyl squarate (also known as squaric acid dibutyl ester or SADBE) is a chemical compound with the molecular formula C12H18O4. It is the dibutyl derivative of squaric acid.
Medically, it is used for the treatment of warts and for treating alopecia areata or alopecia totalis (autoimmune hair loss) through topical immunotherapy involving the production of an allergic rash. Dibutyl squarate is currently undergoing trials for use in treating herpes labialis (cold sores).